Resultados de procura - Incorvaia C

Diagnosis of exercise-induced anaphylaxis: current insights [Corrigendum] por Pravettoni V, Incorvaia C

Ligazón do recurso

New combinations in the treatment of COPD: rationale for aclidinium–formoterol por Incorvaia C, Montagni M, Makri E, Ridolo E

Ligazón do recurso

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide por Ridolo E, Pellicelli I, Gritti B, Incorvaia C

Ligazón do recurso

Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy por Qualizza R, Incorvaia C, Grande R, Makri E, Allegra L

Ligazón do recurso

Two decades with omalizumab: what we still have to learn por Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E

Ligazón do recurso

Striving for optimal bronchodilation: focus on olodaterol por Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E

Ligazón do recurso

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review por Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C

Ligazón do recurso

Omalizumab, an anti-immunoglobulin E antibody: state of the art por Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E

Ligazón do recurso

Shrinking the room for invasive ventilation in hypercapnic respiratory failure por Scarpazza P, Incorvaia C, Melacini C, Cattaneo R, Bonacina C, Riario-Sforza GG, Casali W

Ligazón do recurso

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis por Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C

Ligazón do recurso

In children allergic to ragweed pollen, nasal inflammation is not influenced by monosensitization or polysensitization por Gelardi M, Bosoni M, Morelli M, Beretta S, Incorvaia C, Buttafava S, Landi M, Masieri S, Frati F, Quaranta N, Zuccotti GV

Ligazón do recurso

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] por Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C

Ligazón do recurso

Seasonal changes in nasal cytology in mite-allergic patients por Gelardi M, Peroni DG, Incorvaia C, Quaranta N, De Luca C, Barberi S, Dell'Albani I, Landi M, Frati F, de Beaumont O

Ligazón do recurso

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy por Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P

Ligazón do recurso

5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study por Pastorello EA, Losappio L, Milani S, Manzotti G, Fanelli V, Pravettoni V, Agostinis F, D'Arcais AF, Dell'Albani I, Puccinelli P, Incorvaia C, Frati F

Ligazón do recurso

Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation por Riario-Sforza GG, Pravettoni C, Bencini S, Cattaneo R, Melacini C, Bonacina C, Bernareggi M, Usai P, Raschi S, di Franco G, Amboni P, Incorvaia C, Passalacqua G, Scarpazza P, Casali W

Ligazón do recurso